Ways in which DanGer Will and Will Not Influence Clinical Practice in the US
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker's Bureau - Merck/Schering Plough; Novartis; Pfizer; Regeneron; Roche Diagnostics
- Grant Support/Research Contract - Abbott; Abiomed; Amgen; Anthos Therapeutics; AstraZenca; Daiichi-Sankyo/Elil Lilly and Company; Novartis; Merck/Schering Plough; Pfizer; Regeneron; Roche Diagnostics